Acceleron  

Publications

  • Publication
    ACE-083
    Nov 10, 2016
    A Phase 2 study to evaluate ACE-083, a local muscle therapeutic, in patients with FSHD. FSH Society 2016 Research Connect Conference; November 10, 2016.
    + VIEW FULL Publication
  • Publication
    ACE-083
    Oct 6, 2016
    A Phase 1 Healthy Volunteer Study of ACE-083, a Novel, Locally-Acting Muscle Agent. Patient-Centered Charcot-Marie-Tooth Summit; October 6, 2016.
    + VIEW FULL Publication
  • Publication
    ACE-083
    Sep 9, 2016
    A Phase 1 Healthy Volunteer Study of ACE-083, a Novel, Locally-Acting Muscle Agent. 6th International CMTR Consortium Meeting; September 9, 2016.
    + VIEW FULL Publication
  • Publication
    ACE-083
    Jul 8, 2016
    ACE-083, A Locally-Acting Muscle Agent, Increases Muscle Volume In Healthy Volunteers. 14th International Congress on Neuromuscular Diseases; July 8, 2016.
    + VIEW FULL Publication
  • Publication
    ACE-083
    Apr 2, 2016
    ACE-083, a Locally-Acting TGF-Beta Superfamily Ligand Trap, Increases Muscle Volume of Targeted Muscle: Preliminary Results from a Phase 1 Dose Escalation Study in Healthy Volunteers. ENDO 2016; April 1-4, 2016.
    + VIEW FULL Publication
  • Publication
    ACE-083
    Mar 21, 2016
    ACE-083, a locally-acting TGF-beta superfamily ligand trap, increases muscle volume of targeted muscle: Preliminary results from a Phase 1 dose escalation study in healthy volunteers. 2016 MDA Clinical Conference; March 20-23, 2016.
    + VIEW FULL Publication
  • Publication
    ACE-083
    Mar 21, 2016
    ACE-083, a Locally-Acting TGF-β Superfamily Ligand Trap, Increases Muscle Mass and Strength in a Mouse Model of ALS. 2016 MDA Clinical Conference; March 20-23, 2016.
    + VIEW FULL Publication
  • Publication
    ACE-083
    Dec 5, 2015
    Phase 1 dose escalation study of ACE-083 in healthy volunteers: Preliminary results for a locally acting muscle therapeutic. The Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD) Conference; December 2015.
    + VIEW FULL Publication
  • Publication
    ACE-083
    Oct 5, 2015
    Poster Presentation – A phase 1 dose escalation study of ACE-083, a locally-acting muscle therapeutic, in healthy volunteers. FSHD International Research Consortium; October 5, 2015
    + VIEW FULL Publication
  • Publication
    ACE-083
    Oct 1, 2015
    ACE-083 Increases Muscle Hypertrophy and Strength in C57BL/6 Mice . 20th International Congress of the World Muscle Society; October 1, 2015
    + VIEW FULL Publication
  • Publication
    ACE-083
    Oct 9, 2014
    ACE-083, a Ligand Trap for Members of the TGF-β Superfamily, Increases Muscle Mass Locally in a Mouse Model of Duchenne Muscular Dystrophy . 19th International Congress of the World Muscle Society; October 9, 2014
    + VIEW FULL Publication
  • Publication
    ACE-083
    Jul 7, 2014
    A Modified Cysteine Knot Ligand Trap of the TGF-β Superfamily, ACE-083, Increases Muscle Mass Locally in Mice. 13th International Congress on Neuromuscular Diseases; July 7, 2014
    + VIEW FULL Publication